R. Kerkhoven
Molecular Biology · 2002–2013
A researcher in the Science corpus: 5 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 54 citations into it
- Cancer Research — 9 citations into it
Whom R. Kerkhoven trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from R. Kerkhoven's perspective
Ordered by how strongly the researchers R. Kerkhoven trusts endorse each paper. Same corpus, a different order for every researcher.
- A System for Stable Expression of Short Interfering RNAs in Mammalian Cells (Science)
- Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. (Seminars in Cell and Developmental Biology)
- A novel ubiquitin ligase is deficient in Fanconi anemia (Nature Genetics)
- Biallelic Inactivation of BRCA2 in Fanconi Anemia (Science)
- CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members (Nature)
- Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization (Nature)
- Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB (Nature)
- Stable suppression of tumorigenicity by virus-mediated RNA interference. (Cancer Cell)
- Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. (Science)
- Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. (Journal of the National Cancer Institute)
Their papers
- Gene expression profiling predicts clinical outcome of breast cancer (2002) — 9,976 citations
- The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. (2005) — 625 citations
- Molecular maps of the reorganization of genome – nuclear lamina interactions during differentiation (2010) — 1,051 citations
- FoxM1 is required for execution of the mitotic programme and chromosome stability (2005) — 850 citations
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma (2013) — 827 citations